514 related articles for article (PubMed ID: 33983575)
1. Epigenetic Regulation in Breast Cancer.
Nam HJ; Baek SH
Adv Exp Med Biol; 2021; 1187():103-119. PubMed ID: 33983575
[TBL] [Abstract][Full Text] [Related]
2. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
3. Overview of Histone Modification.
Zhang Y; Sun Z; Jia J; Du T; Zhang N; Tang Y; Fang Y; Fang D
Adv Exp Med Biol; 2021; 1283():1-16. PubMed ID: 33155134
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
Shukla S; Penta D; Mondal P; Meeran SM
Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic reprogramming in breast cancer: from new targets to new therapies.
Katz TA; Huang Y; Davidson NE; Jankowitz RC
Ann Med; 2014 Sep; 46(6):397-408. PubMed ID: 25058177
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in breast cancer: what's new?
Huang Y; Nayak S; Jankowitz R; Davidson NE; Oesterreich S
Breast Cancer Res; 2011; 13(6):225. PubMed ID: 22078060
[TBL] [Abstract][Full Text] [Related]
8. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
10. Histone Modifications and their Role in Colorectal Cancer (Review).
Qin J; Wen B; Liang Y; Yu W; Li H
Pathol Oncol Res; 2020 Oct; 26(4):2023-2033. PubMed ID: 31055775
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic modifications in luminal breast cancer.
Abdel-Hafiz HA; Horwitz KB
Epigenomics; 2015 Aug; 7(5):847-62. PubMed ID: 25689414
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
17. Investigation of epigenetics in kidney cell biology.
Li LX; Agborbesong E; Zhang L; Li X
Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Therapies and Potential Drugs for Treating Human Cancer.
Lin SQ; Li X
Curr Drug Targets; 2020; 21(11):1068-1083. PubMed ID: 32209040
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
Walsh L; Gallagher WM; O'Connor DP; NĂ Chonghaile T
Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
[TBL] [Abstract][Full Text] [Related]
20. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]